Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
| Study Number Sort descending | Lead Group | Study Title | CIRB | Study Status | |
|---|---|---|---|---|---|
| EA2131 | ECOG-ACRIN | A Phase I and Randomized Phase II Study of Nab-Paclitaxel/Gemcitabine with or without AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas | Adult CIRB - Early Phase Emphasis | Available to Open | |
| EA2142 | ECOG-ACRIN | Randomized Phase II Study of Platinum and Etoposide versus Temozolomide and Capecitabine in Patients with Advanced G3 Non-Small Cell Gastroenteropancreatic Neuroendocrine Tumors including Poorly Differentiated Neuroendocrine Carcinomas and Well-Differentiated Neuroendocrine Neoplasms | Adult CIRB - Early Phase Emphasis | Available to Open | |
| EA2161 | ECOG-ACRIN | A Phase II Study of MLN0128 (TAK-228) in Rapalog-Resistant Advanced Pancreatic Neuroendocrine Tumors (PNET) | Adult CIRB - Late Phase Emphasis | Available to Open | |
| EA2165 | ECOG-ACRIN | A Randomized Phase II Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer | Adult CIRB - Late Phase Emphasis | Available to Open | |
| EA2174 | ECOG-ACRIN | A Phase II/III Study of Peri-operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma | Adult CIRB - Late Phase Emphasis | Available to Open | |
| EA2176 | ECOG-ACRIN | A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Naïve Metastatic Anal Cancer Patients | Adult CIRB - Late Phase Emphasis | Available to Open | |
| EA2182 | ECOG-ACRIN | A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE) | Adult CIRB - Late Phase Emphasis | Available to Open | |
| EA2183 | ECOG-ACRIN | A Phase III Study of Consolidative Radiotherapy in Patients with Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA) | Adult CIRB - Late Phase Emphasis | Available to Open | |
| EA2185 | ECOG-ACRIN | Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs | Cancer Prevention and Control CIRB | Available to Open | |
| EA2186 | ECOG-ACRIN | A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naïve Metastatic Pancreatic Cancer (GIANT) | Adult CIRB - Late Phase Emphasis | Available to Open |